{
  "id": 2864,
  "text": "717.Rushdan, M.N., et al.Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 717.Rushdan, M.N., et al.Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据GOG评分系统，对于FIGO Ib期且淋巴结阴性的宫颈癌患者，在根治性手术后的辅助盆腔放疗需结合患者的具体危险因素进行个体化评估和制定。GOG评分主要关注肿瘤大小、间质浸润深度及血管淋巴管间隙受侵情况等因素，这些变量实际上决定了是否需要辅助盆腔放疗，以及放疗的范围。\n\n一般而言：\n1. **低风险患者**（GOG评分低）：如肿瘤体积较小（<2 cm）、间质侵润深度较浅（<10 mm），且无淋巴血管间隙受侵的患者，术后可能无需进行辅助盆腔放疗。但需随访观察。\n   \n2. **中高风险患者**（GOG评分高）：若肿瘤较大（≥4 cm）、间质深侵明显，或伴随明确的淋巴血管间隙受侵，则辅助盆腔放疗可能有助于降低局部复发风险。这类患者需定制化放疗范围，原则上应覆盖宫颈切除床及相关高危区域。\n\n精准实施放疗的关键是基于手术及病理结果评估患者复发风险，从而确保治疗既有效又避免过度治疗。",
  "query": "基于GOG评分，如何为FIGO Ib期淋巴结阴性的宫颈癌患者在根治性手术后定制辅助盆腔放疗的范围和适应症？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 基于GOG评分，如何为FIGO Ib期淋巴结阴性的宫颈癌患者在根治性手术后定制辅助盆腔放疗的范围和适应症？\n\n<reference text>: 717.Rushdan, M.N., et al.Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据GOG评分系统，对于FIGO Ib期且淋巴结阴性的宫颈癌患者，在根治性手术后的辅助盆腔放疗需结合患者的具体危险因素进行个体化评估和制定。GOG评分主要关注肿瘤大小、间质浸润深度及血管淋巴管间隙受侵情况等因素，这些变量实际上决定了是否需要辅助盆腔放疗，以及放疗的范围。\n\n一般而言：\n1. **低风险患者**（GOG评分低）：如肿瘤体积较小（<2 cm）、间质侵润深度较浅（<10 mm），且无淋巴血管间隙受侵的患者，术后可能无需进行辅助盆腔放疗。但需随访观察。\n   \n2. **中高风险患者**（GOG评分高）：若肿瘤较大（≥4 cm）、间质深侵明显，或伴随明确的淋巴血管间隙受侵，则辅助盆腔放疗可能有助于降低局部复发风险。这类患者需定制化放疗范围，原则上应覆盖宫颈切除床及相关高危区域。\n\n精准实施放疗的关键是基于手术及病理结果评估患者复发风险，从而确保治疗既有效又避免过度治疗。"
}